Literature DB >> 418008

[In vitro effect of fosfomycin against Pseudomonas aeruginosa compared to carbenicillin, gentamycin and polymyxin B].

R Ansorg.   

Abstract

The activity of fosfomycin against Pseudomonas aeruginosa (78 serotyped strains isolated from clinical specimens) is considerably more dependent on test conditions than that of carbenicillin, polymyxin B or gentamicin. Using a degree of standardization of the micro-serial dilution test and agar diffusion test (Iso-Sensitest broth and agar), which yields a high degree of correlation between the values of both techniques with carbenicillin and gentamicin, a moderate degree of correlation is obtained with fosfomycin. In regard to minimal inhibitory concentration (MIC) values in human serum and human urine, fewer "false" results are obtained in Iso-Sensitest broth than in Mueller Hinton broth and in particular glucose caseinhydrolysate broth. On the basis of MIC values in Iso-Sensitest broth P. aeruginosa is much more sensitive to polymyxin B, carbenicillin and gentamicin than to fosfomycin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 418008     DOI: 10.1007/bf01642162

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  12 in total

1.  A new synthesis of the antibiotic phosphonomycin.

Authors:  E J Glamkowski; G Gal; R Purick; A J Davidson; M Sletzinger
Journal:  J Org Chem       Date:  1970-10       Impact factor: 4.354

2.  The evolution of the sensitivity to fosfomycin over the past two years.

Authors:  M Gobernado; M Santos; N Diosdado; F Pérez
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

3.  Evolution of sensitivity to fosfomycin in bacteria isolated in 1973, 1974 and 1975 in the Servicio de Microbiologia y Epidemiologia of the 'Clinica Puerta de Hierro', Madrid.

Authors:  D Dámaso; M Moreno-López; J Martínez-Beltrán
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

4.  Evolution of sensitivity to fosfomycin at Jimenez Diaz Foundation.

Authors:  J M Alés
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

5.  Evolution of bacterial sensitivity to fosfomycin in the Cindad Sanitaria 'Francisco Franco' in Barcelona.

Authors:  E Crespo; J A Roca de Viñals
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

6.  Susceptibility to fosfomycin of hospital strains isolated in Nantes (France). Frequency of mutation to resistance.

Authors:  A L Courtieu; H Drugeon; S Billaudel
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

7.  Fosfomycin and plasmidic resistance.

Authors:  F Baquero; M López-Brea; A Valls; T Cañedo
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

8.  Fosfomycin: Laboratory studies.

Authors:  H B Woodruff; J M Mata; S Hernández; S Mochales; A Rodríguez; E O Stapley; H Wallick; A K Miller; D Hendlin
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

9.  Fosfomycin, antimicrobial activity in vitro and in vivo.

Authors:  S Goto
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

10.  The action of fosfomycin on the growth of Pseudomonas aeruginosa.

Authors:  C Hardisson; J Llaneza
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

View more
  2 in total

1.  [Microbiological studies before and after endoscopic papillotomy (EPT)].

Authors:  R Ansorg; U R Fölsch; N Kieslich; R Arnold
Journal:  Infection       Date:  1983 Sep-Oct       Impact factor: 3.553

2.  In vitro investigations with fosfomycin on Mueller-Hinton agar with and without glucose-6-phosphate.

Authors:  H Grimm
Journal:  Infection       Date:  1979       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.